BioSpace News Archive

Novasep Industrializes Potato Protein Purification Unit for Solanic B.V.

This represents a step forward for the plant-based protein purification industry, with the first compact bed chromatography system for the purification of vegetable proteins

October 22, 2018
·
1 min read
Drug Development

Epizyme Reports Positive Data on Tazemetostat in Epithelioid Sarcoma from its Phase 2 Trial Cohort at ESMO

Updated Efficacy and Safety Data Support Company’s Planned Submission of a New Drug Application for Tazemetostat for Epithelioid Sarcoma in the First Half of 2019

October 22, 2018
·
8 min read
Genetown

SeraCare Announces Launch of Expanded NTRK Reference Material Panel

An important new tool for labs seeking to detect NTRK gene fusions by next-generation sequencing

October 22, 2018
·
3 min read
FDA

Biohaven Receives Authorization to Proceed from FDA and Doses First Subject with BHV-3500, Third-Generation, Small Molecule CGRP-Receptor Antagonist

BHV-3500 is the first small molecule calcitonin gene-related peptide (CGRP) receptor antagonist to be administered in an intranasal (IN) formulation in human testing

October 22, 2018
·
7 min read
Drug Development

Genentech’s Tecentriq Plus Chemotherapy (Carboplatin and Abraxane) as an Initial Treatment Helped People With Advanced Non-Squamous Non-Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy Alone

The Phase III IMpower130 study investigating the Tecentriq plus chemotherapy combination demonstrated a significant overall survival (OS) and progression-free survival (PFS) benefit

October 22, 2018
·
12 min read
Drug Development

Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrates Durable Four-Year Survival Benefits in Patients with Advanced Melanoma

More than half (53%) of patients treated with Opdivo plus Yervoy survived to four years, with median overall survival (OS) not yet reached

October 22, 2018
·
37 min read
Business

NextLevel Health Partners, Inc., Announces Partnership With NowPow To Improve The Health Outcomes Of Residents Across Cook County

Innovative Partnership Will Allow Both Community-Based Companies to Better Manage and Address the Social Determinants Impacting the Health and Wellness of Cook County Residents

October 22, 2018
·
3 min read
Drug Development

Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) Demonstrates Durable Clinical Benefit in Previously Untreated Patients with MSI-H or dMMR Metastatic Colorectal Cancer

Combination showed 60% objective response rate (investigator-assessed)

October 22, 2018
·
35 min read
Drug Development

amcure Presents First Clinical Data for Lead Compound AMC303 at ESMO 2018 Congress

Data Presented in Proffered Oral Presentation Demonstrates Favorable Safety Profile of AMC303 Supporting Finalization of Phase 1b Extension Cohort

October 22, 2018
·
4 min read
Outline of New ESMO Guidelines Indicates Inclusion of FOTIVDA®▼ (Tivozanib) for Patients with Advanced Renal Cell Carcinoma

EUSA Pharma (EUSA) welcomes the news that FOTIVDA®▼ (tivozanib) is expected to be included in the upcoming European Society of Medical Oncology (ESMO) clinical practice guidelines for advanced renal cell carcinoma (aRCC), anticipated to be published at the end of this year.

October 22, 2018
·
6 min read